Skip to main content
Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
2.040
0.00 (0.00%)
At close: Nov 4, 2024, 4:00 PM
2.000
-0.040 (-1.96%)
Pre-market: Nov 5, 2024, 4:00 AM EST

Virax Biolabs Group Revenue

In the fiscal year ending March 31, 2024, Virax Biolabs Group had annual revenue of $156.42K with 1,727.11% growth. Virax Biolabs Group had revenue of $79.92K in the half year ending March 31, 2024.

Revenue (ttm)
$156.42K
Revenue Growth
+1,727.11%
P/S Ratio
26.17
Revenue / Employee
$9,201
Employees
17
Market Cap
8.86M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024156.42K147.86K1,727.11%
Mar 31, 20238.56K--
Mar 31, 2022---
Mar 31, 2021123.82K23.94K23.97%
Mar 31, 202099.88K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
XWELL 32.88M
Streamline Health Solutions 20.30M
NeuroMetrix 4.38M
Ensysce Biosciences 1.44M
Soligenix 494.62K
BioCardia 428.00K
Revenue Rankings

VRAX News

More News